STAMFORD, Conn., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Avidity Biosciences, Inc. (NASDAQ:RNA) ("Avidity" or the "Company") on behalf of the Company's investors to determine whether actions taken by Avidity's board of directors to entrench themselves and avoid being held ...

Full story available on Benzinga.com